Target JAK2/IL11-mediated Pathway By LY2784544 To Treat Platinum Drug Resistant Ovarian Cancer
Technology
E-130-2017
Patent ID
E-130-2017-0-US-03
Country
US
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
Application Number
16/500,959
IC
NCATS
Date Filed
Date Issued
Patent PDF